Behavioral Neuroplasticity: Psychedelics for Alcohol Use Disorder
Nathan Sackett, MDAda 2
There is increasing interest in psychedelics for a range of psychiatric disorders. This talk is meant to provide history and context around current studies exploring psychedelics for AUD.
Learning Objectives
- Be able to articulate some basic history of psychedelics for AUD.
- Review evidence of Psychedelics for AUD
- Explore some potential mechanisms.
Nathan Sackett, MD, MS, is the Director of the Center for Novel Therapeutics in Addiction Psychiatry and Acting Assistant Professor in the University of Washington Department of Psychiatry & Behavioral Sciences. His focus is on the intersection between substance use and psychiatric disorders and the use of psychedelics to treat substance use disorders with a particular interest in how psychedelics can augment the psychotherapeutic process and facilitate behavioral change.
Thu 9:30 am - 10:45 am